Self-Reported HIV and HCV Screening Rates and Serostatus Among Substance Abuse Treatment Patients

AIDS Behav. 2016 Jan;20(1):204-14. doi: 10.1007/s10461-015-1074-2.

Abstract

Substance users are at increased risk for HIV and HCV infection. Still, many substance use treatment programs (SUTP) fail to offer HIV/HCV testing. The present secondary analysis of screening data from a multi-site randomized trial of rapid HIV testing examines self-reported HIV/HCV testing patterns and serostatus of 2473 SUTP patients in 12 community-based sites that had not previously offered on-site testing. Results indicate that most respondents screened for the randomized trial tested more than a year prior to intake for HIV (52 %) and HCV (38 %). Prevalence rates were 3.6 and 30 % for HIV and HCV, respectively. The majority of participants that were HIV (52.2 %) and HCV-positive (40.5 %) reported having been diagnosed within the last 1-5 years. Multivariable logistic regression showed that members of high-risk groups were more likely to have tested. Bundled HIV/HCV testing and linkage to care issues are recommended for expanding testing in community-based SUTP settings.

Keywords: Community based substance abuse treatment programs; HIV/HCV sceening and serostatus; HIV/HCV testing and linkage to care; Substance abuse treatment patients.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Drug Users / psychology
  • Drug Users / statistics & numerical data*
  • Female
  • HIV Infections / diagnosis
  • HIV Infections / epidemiology*
  • HIV Seronegativity
  • HIV Seropositivity / epidemiology
  • HIV Seroprevalence
  • Hepatitis C / diagnosis
  • Hepatitis C / epidemiology*
  • Humans
  • Logistic Models
  • Male
  • Mass Screening / statistics & numerical data*
  • Middle Aged
  • Prevalence
  • Self Report*
  • Sexual Behavior
  • Substance Abuse, Intravenous / complications
  • Substance Abuse, Intravenous / epidemiology*
  • Substance Abuse, Intravenous / therapy